FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110349079> ?p ?o ?g. }

• W2110349079 endingPage "1584" @default.
• W2110349079 startingPage "1577" @default.
• W2110349079 abstract "Endogenous adenosine might cause or perpetuate bradyasystole. Our aim was to determine whether aminophylline, an adenosine antagonist, increases the rate of return of spontaneous circulation (ROSC) after out-of-hospital cardiac arrest.In a double-blind trial, we randomly assigned 971 patients older than 16 years with asystole or pulseless electrical activity at fewer than 60 beats per minute, and who were unresponsive to initial treatment with epinephrine and atropine, to receive intravenous aminophylline (250 mg, and an additional 250 mg if necessary) (n=486) or placebo (n=485). The patients were enrolled between January, 2001 and September, 2003, from 1886 people who had had cardiac arrests. Standard resuscitation measures were used for at least 10 mins after the study drug was administered. Analysis was by intention-to-treat. This trial is registered with the ClinicalTrials.gov registry with the number NCT00312273.Baseline characteristics and survival predictors were similar in both groups. The median time from the arrival of the advanced life-support paramedic team to study drug administration was 13 min. The proportion of patients who had an ROSC was 24.5% in the aminophylline group and 23.7% in the placebo group (difference 0.8%; 95% CI -4.6% to 6.2%; p=0.778). The proportion of patients with non-sinus tachyarrhythmias after study drug administration was 34.6% in the aminophylline group and 26.2% in the placebo group (p=0.004). Survival to hospital admission and survival to hospital discharge were not significantly different between the groups. A multivariate logistic regression analysis showed no evidence of a significant subgroup or interactive effect from aminophylline.Although aminophylline increases non-sinus tachyarrhythmias, we noted no evidence that it significantly increases the proportion of patients who achieve ROSC after bradyasystolic cardiac arrest." @default.
• W2110349079 created "2016-06-24" @default.
• W2110349079 creator A5001026024 @default.
• W2110349079 creator A5009308534 @default.
• W2110349079 creator A5015102929 @default.
• W2110349079 creator A5019487072 @default.
• W2110349079 creator A5022082771 @default.
• W2110349079 creator A5029404079 @default.
• W2110349079 creator A5033154988 @default.
• W2110349079 creator A5037587091 @default.
• W2110349079 creator A5040229094 @default.
• W2110349079 creator A5048542504 @default.
• W2110349079 creator A5049164998 @default.
• W2110349079 creator A5057198230 @default.
• W2110349079 creator A5061434854 @default.
• W2110349079 creator A5074495980 @default.
• W2110349079 creator A5079286366 @default.
• W2110349079 date "2006-05-01" @default.
• W2110349079 modified "2023-09-30" @default.
• W2110349079 title "Aminophylline in bradyasystolic cardiac arrest: a randomised placebo-controlled trial" @default.
• W2110349079 cites W1512068530 @default.
• W2110349079 cites W1517594284 @default.
• W2110349079 cites W1874700596 @default.
• W2110349079 cites W1964061074 @default.
• W2110349079 cites W1978587252 @default.
• W2110349079 cites W1994451030 @default.
• W2110349079 cites W2000778146 @default.
• W2110349079 cites W2003922776 @default.
• W2110349079 cites W2011539902 @default.
• W2110349079 cites W2015569273 @default.
• W2110349079 cites W2031861865 @default.
• W2110349079 cites W2033850501 @default.
• W2110349079 cites W2034754601 @default.
• W2110349079 cites W2052144319 @default.
• W2110349079 cites W2057966909 @default.
• W2110349079 cites W2063530058 @default.
• W2110349079 cites W2080549390 @default.
• W2110349079 cites W2080775297 @default.
• W2110349079 cites W2081777772 @default.
• W2110349079 cites W2085291205 @default.
• W2110349079 cites W2085505045 @default.
• W2110349079 cites W2089537280 @default.
• W2110349079 cites W2110944531 @default.
• W2110349079 cites W2120831964 @default.
• W2110349079 cites W2121387975 @default.
• W2110349079 cites W2139239007 @default.
• W2110349079 cites W2140440432 @default.
• W2110349079 cites W2148583060 @default.
• W2110349079 cites W2161252442 @default.
• W2110349079 cites W2186176830 @default.
• W2110349079 cites W4233894578 @default.
• W2110349079 cites W4255923195 @default.
• W2110349079 doi "https://doi.org/10.1016/s0140-6736(06)68694-7" @default.
• W2110349079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16698410" @default.
• W2110349079 hasPublicationYear "2006" @default.
• W2110349079 type Work @default.
• W2110349079 sameAs 2110349079 @default.
• W2110349079 citedByCount "37" @default.
• W2110349079 countsByYear W21103490792012 @default.
• W2110349079 countsByYear W21103490792013 @default.
• W2110349079 countsByYear W21103490792014 @default.
• W2110349079 countsByYear W21103490792015 @default.
• W2110349079 countsByYear W21103490792016 @default.
• W2110349079 countsByYear W21103490792019 @default.
• W2110349079 countsByYear W21103490792020 @default.
• W2110349079 countsByYear W21103490792021 @default.
• W2110349079 countsByYear W21103490792023 @default.
• W2110349079 crossrefType "journal-article" @default.
• W2110349079 hasAuthorship W2110349079A5001026024 @default.
• W2110349079 hasAuthorship W2110349079A5009308534 @default.
• W2110349079 hasAuthorship W2110349079A5015102929 @default.
• W2110349079 hasAuthorship W2110349079A5019487072 @default.
• W2110349079 hasAuthorship W2110349079A5022082771 @default.
• W2110349079 hasAuthorship W2110349079A5029404079 @default.
• W2110349079 hasAuthorship W2110349079A5033154988 @default.
• W2110349079 hasAuthorship W2110349079A5037587091 @default.
• W2110349079 hasAuthorship W2110349079A5040229094 @default.
• W2110349079 hasAuthorship W2110349079A5048542504 @default.
• W2110349079 hasAuthorship W2110349079A5049164998 @default.
• W2110349079 hasAuthorship W2110349079A5057198230 @default.
• W2110349079 hasAuthorship W2110349079A5061434854 @default.
• W2110349079 hasAuthorship W2110349079A5074495980 @default.
• W2110349079 hasAuthorship W2110349079A5079286366 @default.
• W2110349079 hasConcept C126322002 @default.
• W2110349079 hasConcept C142724271 @default.
• W2110349079 hasConcept C204787440 @default.
• W2110349079 hasConcept C27081682 @default.
• W2110349079 hasConcept C2775859304 @default.
• W2110349079 hasConcept C2776202631 @default.
• W2110349079 hasConcept C2776818218 @default.
• W2110349079 hasConcept C2777055891 @default.
• W2110349079 hasConcept C2778165595 @default.
• W2110349079 hasConcept C2778619729 @default.
• W2110349079 hasConcept C42219234 @default.
• W2110349079 hasConcept C71924100 @default.
• W2110349079 hasConceptScore W2110349079C126322002 @default.
• W2110349079 hasConceptScore W2110349079C142724271 @default.
• W2110349079 hasConceptScore W2110349079C204787440 @default.

• next